•1 min read•from Science News
An experimental new drug for stiff person syndrome restores mobility
Our take
A groundbreaking experimental drug for stiff person syndrome demonstrates promising results by restoring mobility in affected individuals. Utilizing CAR T cell therapy, this innovative treatment targets and eliminates the source of rogue antibodies responsible for the autoimmune disorder. Early trials show significant improvements in walking speed for participants, including those with a condition similar to that affecting renowned singer Celine Dion.
CAR T cell therapy wipes out rogue antibodies' source and improves walking speed in people with the same autoimmune disorder that affects Celine Dion.
Read on the original site
Open the publisher's page for the full experience
Tagged with
#stiff person syndrome#CAR T cell therapy#experimental drug#autoimmune disorder#rogue antibodies#mobility#walking speed#Celine Dion#improves#restores#therapy#treatment#immunotherapy#health#research#autoimmunity#symptoms#neurology#clinical trial#disease